Atria Investments’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$813K Sell
1,682
-1,122
-40% -$298K 0.01% 1229
2026
Q1
$307K Sell
2,804
-117
-4% -$16.7K ﹤0.01% 1742
2025
Q4
$486K Buy
2,921
+623
+27% +$104K 0.01% 1472
2025
Q3
$450K Sell
2,298
-204
-8% -$33.5K 0.01% 1479
2025
Q2
$226K Buy
+2,502
New +$198K ﹤0.01% 1852
2025
Q1
– Sell
-2,285
Closed -$303K – 2016
2024
Q4
$303K Buy
+2,285
New +$214K ﹤0.01% 1592

Other funds holding ALAB

Atria Investments's ALAB Position: Q2 2026 in Review

Atria Investments reduced its Astera Labs (ALAB) stake by 40% in Q2 2026, selling an estimated $298K and leaving 1,682 shares worth $813K. The position accounts for 0.01% of the portfolio, ranked #1229.

Atria Investments first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Atria Investments held 1,682 shares of Astera Labs worth $813K as of Q2 2026.
  • Atria Investments sold 1,122 Astera Labs shares in Q2 2026, an estimated $298K.
  • Astera Labs made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1229 holding.
  • Atria Investments first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.